Evidence map›Paper›PMID 31324942›Full record

ArticleEuropean biophysics journal : EBJ2019

Unveiling the binding and orientation of the antimicrobial peptide Plantaricin 149 in zwitterionic and negatively charged membranes.

Patricia S Kumagai, Victor K Sousa, Maressa Donato, Rosangela Itri, Leila M Beltramini, Ana P U Araujo, Jochen Buerck, B A Wallace, Jose L S Lopes

Abstract read
PubMed Publisher
In one paragraph

Article in European biophysics journal : EBJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Patricia S KumagaiInstituto de Física de São Carlos, Universidade de São Paulo, São Carlos, SP, 13563-120, Brazil.ORCID http://orcid.org/0000-0001-7546-3091
Victor K SousaDepartamento Física Aplicada, Instituto de Física, Universidade de São Paulo, Rua do Matão 1371, São Paulo, SP, 05508-090, Brazil.ORCID http://orcid.org/0000-0002-0430-4330
Maressa DonatoDepartamento Física Aplicada, Instituto de Física, Universidade de São Paulo, Rua do Matão 1371, São Paulo, SP, 05508-090, Brazil.ORCID http://orcid.org/0000-0002-5748-3723
Rosangela ItriDepartamento Física Aplicada, Instituto de Física, Universidade de São Paulo, Rua do Matão 1371, São Paulo, SP, 05508-090, Brazil.ORCID http://orcid.org/0000-0001-9311-0804
Leila M BeltraminiInstituto de Física de São Carlos, Universidade de São Paulo, São Carlos, SP, 13563-120, Brazil.ORCID http://orcid.org/0000-0001-5741-8238
Ana P U AraujoInstituto de Física de São Carlos, Universidade de São Paulo, São Carlos, SP, 13563-120, Brazil.ORCID http://orcid.org/0000-0001-5455-084X
Jochen BuerckInstitute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology (KIT), POB 3640, 76021, Karlsruhe, Germany.ORCID http://orcid.org/0000-0002-2256-9498
B A WallaceInstitute of Structural and Molecular Biology, Birkbeck College, University of London, London, WC1E 7HX, UK.ORCID http://orcid.org/0000-0001-9649-5092
Jose L S LopesDepartamento Física Aplicada, Instituto de Física, Universidade de São Paulo, Rua do Matão 1371, São Paulo, SP, 05508-090, Brazil. zeluiz@if.usp.br.ORCID http://orcid.org/0000-0003-1281-0521

Funding

Biotechnology and Biological Sciences Research Council N012763/1Biotechnology and Biological Sciences Research Council P02409Conselho Nacional de Desenvolvimento Científico e Tecnológico 303513/2016-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 406429/2016-2Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/07600-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/50347-2Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/19546-7
6 · The paper itself

Abstract

Antimicrobial peptides are a large group of natural compounds which present promising properties for the pharmaceutical and food industries, such as broad-spectrum activity, potential for use as natural preservatives, and reduced propensity for development of bacterial resistance. Plantaricin 149 (Pln149), isolated from Lactobacillus plantarum NRIC 149, is an intrinsically disordered peptide with the ability to inhibit bacteria from the Listeria and Staphylococcus genera, and which is capable of promoting inhibition and disruption of yeast cells. In this study, the interactions of Pln149 with model membranes composed of zwitterionic and/or anionic phospholipids were investigated using a range of biophysical techniques, including isothermal titration calorimetry, surface tension measurements, synchrotron radiation circular dichroism spectroscopy, oriented circular dichroism spectroscopy, and optical microscopy, to elucidate these peptides' mode of interactions and provide insight into their functional roles. In anionic model membranes, the binding of Pln149 to lipid bilayers is an endothermic process and induces a helical secondary structure in the peptide. The helices bind parallel to the surfaces of lipid bilayers and can promote vesicle disruption, depending on peptide concentration. Although Pln149 has relatively low affinity for zwitterionic liposomes, it is able to adsorb at their lipid interfaces, disturbing the lipid packing, assuming a similar parallel helix structure with a surface-bound orientation, and promoting an increase in the membrane surface area. Such findings can explain the intriguing inhibitory action of Pln149 in yeast cells whose cell membranes have a significant zwitterionic lipid composition.

Indexed as

AdsorptionBacteriocinsCell MembraneLipid BilayersProtein BindingSurface TensionUnilamellar LiposomesBacteriocinsLipid Bilayersplantaricin 149Unilamellar LiposomesAntimicrobial peptideMechanism of actionOriented circular dichroism spectroscopyPeptide–lipid interactionsSynchrotron radiation circular dichroism spectroscopy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.